Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.
开创性的首创 HDAC-ROCK 抑制剂作为潜在的多靶点抗癌药物
期刊:Future Medicinal Chemistry
影响因子:3.4
doi:10.1080/17568919.2025.2459589
Beljkas Milan, Ruzic Dusan, Djuric Ana, Vuletic Ana, Tchiehe Guilaine Nchugoua, Jallet Corinne, Cadet-Daniel Véronique, Arimondo Paola B, Santibanez Juan F, Srdic-Rajic Tatjana, Nikolic Katarina, Oljacic Slavica, Petkovic Milos
